Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 202 (Search time: 0.006 seconds).

No. Year Title Type
202 2022

2022Patent

세포 내 존재 단백질과 세포 외부로 분비되는 단백질을 동시 발현하는 이중 발현벡터를 포함하는 암의 예방 또는 치료용 조성물KR10-2021-0039575 (2021.03.26) / 10-2393402 (2022.04.27)원미선임주영
Patent
201 2022

2022Patent

SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물KR10-2019-0129281 (2019.10.17) / 10-2377702-0000 (2022.03.18)염영일; 원미선반현승김보경박경찬
Patent
200 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
199 2022

2022Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
198 2022

2022Article

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young ImBo Kyung KimMi Sun WonJi Hwan Park, et al.
Article
197 2022

2022Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
196 2022

2022Research Project

암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
195 2021

2021Patent

cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물US15/087,563 (2016.03.31) / 10,973,884 (2021.04.13)김동욱원미선김보경; 이영주; 오경진임주영반현승
Patent
194 2021

2021Patent

cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물CN201480064255.2 (2016.05.25) / ZL201480064255.2 (2021.02.26)김동욱원미선; 이영주; 반현승김보경
Patent
193 2021

2021Article

VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung KimMi Sun Won
Article
192 2021

2021Article

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young ImBo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won
Article
191 2021

2021Article

LW1497, an inhibitor of malate dehydrogenase, suppresses TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells by downregulating slugAntioxidants, vol. 10, no. 11, pp. 1674-1674H J Kim; M K Park; H J Byun; M Kim; B Kim; L Yu; T M Nguyen; T H Nguyen; P A Do; E J Kim, et al.
Article
190 2021

2021Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
189 2021

2021Research Project

다중유전체 분석을 통한 비흡연폐암의 신규치료타겟 발굴 및 기전규명연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2022.03.31
Research Project
188 2021

2021Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
187 2021

2021Research Project

[BRIDGE+] 2020년도 대학협력기관 간 융복합 프로그램연구책임자 : 이홍원 / 사업기간 : 2021.09.01 ~ 2022.01.15
Research Project
186 2021

2021Research Project

암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
185 2020

2020Patent

장형 위암의 예후 진단 마커KR10-2018-0125768 (2018.10.22) / 10-2136747-0000 (2020.07.16)원미선김보경김선규박경찬
Patent
184 2020

2020Patent

말릭산 탈수소효소 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물KR10-2018-0027397 (2018.03.08) / 10-2082504 (2020.02.21)원미선반현승김보경
Patent
183 2020

2020Article

DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cellsOncogenesis, vol. 9, pp. 1-1Joo-Young ImBo Kyung Kim; K W Lee; So-Young Chun; Mi-Jung KangMi Sun Won
Article
1 2 3 4 5 6 7 8 9 10 11 11